Loading...
Post-market safety warnings for drugs approved in Canada under the Notice of Compliance with conditions policy
AIMS: Health Canada has developed a pathway to approve drugs that have limited efficacy and safety data, the Notice of Compliance with conditions (NOC/c) policy. Increased safety reporting is required for these drugs but there has not been any systematic review of their post-market safety. This stud...
Na minha lista:
| Udgivet i: | Br J Clin Pharmacol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BlackWell Publishing Ltd
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4415721/ https://ncbi.nlm.nih.gov/pubmed/25393960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12552 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|